Biotech startup Trimph has developed a “glue” intended to help regenerate bone tissue

Despite their usefulness, it’s a social norm to dislike dentists. The bottom line is that most prefer not to have another person poking metal objects around the inside of their mouth, particularly if said object is a drill.

At an even more uncomfortable end of the dentistry scale is tooth extraction, which often leads to more pain than discomfort.

Enter Trimph, an Australian biomedical startup working to commercialise a range of medical technologies, including its patented TrimphDent, a product to be used to accelerate the healing of hard and soft tissue post tooth extraction.

By quickly healing the damaged tissue, Trimph is ultimately intended to reduce the pain and discomfort felt after a tooth has been extracted, an “inherently traumatic procedure”, and reduce the need for a secondary operation used to tend to complications resulting from the initial extraction.

As Trimph’s cofounder Terence Abrams explained, the technology leverages the company’s “platform polymer technology”, which emerged from cofounder Ali Fathi’s PhD project at the University of Sydney.

Naturally, polymers, or large molecules, string together to make up natural materials such as wool, silk and rubber. Read more

James Ward - Startup Daily - 17 Aug 2017

Comments

We welcome relevant, respectful comments.
Please read our Comment Policy before commenting.
We also welcome direct feedback via Contact Us.
You may also want to ask our librarians.

Be the first to write a comment